This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
Mixed picture: 1 strengths against 1 watch-outs. Weigh them against your own goals.
For a moderate profile, none of the items above crosses the watch-out thresholds set by the team.
In plain words
For company 7828, profitability remains moderate with a return on equity of 9.6% and a net margin of 38.3%, accompanied by a light debt load with liabilities at 18.9% of total assets in Q3 2026. However, free cash flow was negative in 2025 at -370 NT$ million as spending exceeded operating cash. Additionally, there are 2 verified alerts, including the latest on 2026-11-10 concerning a board resolution to buy back treasury stock (公告本公司董事會決議買回庫藏股), and 1 filing is waiting for human review. Overall, this reflects a mixed picture of strengths and watch-outs for a moderate profile. Ultimately, the final decision rests with the investor.
Written by gemini-3.6-flash from the facts above; every number was checked against them.
Strengths
+Liabilities are only 18.9% of total assets (Q3 2026): a light debt load. source (Financials) →
Watch-outs
!Free cash flow was negative in 2025: -370 NT$ million, so spending exceeded operating cash. source (Financials) →
What to check before deciding
?What is the spending for, and when does it start paying back?
What the analysis found
·ProfitabilityReturn on equity 9.6% with a 38.3% net margin: moderate profitability. source →
+DebtLiabilities are only 18.9% of total assets (Q3 2026): a light debt load. source →
!Cash flowFree cash flow was negative in 2025: -370 NT$ million, so spending exceeded operating cash. source →
·Filings2 verified alert(s); latest on 2026-11-10: 公告本公司董事會決議買回庫藏股 source →
·Filings1 filing(s) are held or rejected and wait for human review. source →